海外-话题@MedSci

#海外#

64篇内容 | 999人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1748961, encodeId=55bd1e489611d, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=恒瑞医药率先进军海外创新药市场，正式推出Luzsana公司, objectType=article, longId=727332, objectId=1d36e2733231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d36e2733231, replyNumber=0, likeNumber=39, createdTime=2022-08-23, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d36e2733231, moduleTitle=恒瑞医药率先进军海外创新药市场，正式推出Luzsana公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d36e2733231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748960, encodeId=4d221e489605a, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=2022年4月23日简报：上海昨日新增本土病例“2736+20634”例，死亡12例；香港将从5月1日起允许非香港居民从海外入境；美国纽约BA.2.12和BA.2.12.1在迅速传播, objectType=article, longId=724853, objectId=3641e24853b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3641e24853b0, replyNumber=0, likeNumber=41, createdTime=2022-09-16, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3641e24853b0, moduleTitle=2022年4月23日简报：上海昨日新增本土病例“2736+20634”例，死亡12例；香港将从5月1日起允许非香港居民从海外入境；美国纽约BA.2.12和BA.2.12.1在迅速传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3641e24853b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748959, encodeId=b4ea1e4895980, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=香港新增574例新冠肺炎确诊病例，5月起容许非香港居民从海外入境（2022.04.22）, objectType=article, longId=724843, objectId=e8c5e2484350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8c5e2484350, replyNumber=0, likeNumber=31, createdTime=2022-10-20, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8c5e2484350, moduleTitle=香港新增574例新冠肺炎确诊病例，5月起容许非香港居民从海外入境（2022.04.22）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8c5e2484350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748962, encodeId=c4ce1e4896276, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=【海外病例精选18期】黄色肉芽肿性肾盂肾炎, objectType=article, longId=229356, objectId=1107229356ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1107229356ed, replyNumber=0, likeNumber=43, createdTime=2022-04-10, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1107229356ed, moduleTitle=【海外病例精选18期】黄色肉芽肿性肾盂肾炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1107229356ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748956, encodeId=39ba1e4895660, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=荣昌生物与西雅图基因签约：26亿美元！维迪西妥单抗创单药海外授权新纪录, objectType=article, longId=215528, objectId=f3ec21552816, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ec21552816, replyNumber=0, likeNumber=31, createdTime=2022-05-03, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ec21552816, moduleTitle=荣昌生物与西雅图基因签约：26亿美元！维迪西妥单抗创单药海外授权新纪录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ec21552816)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748958, encodeId=8cd61e48958a3, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验, objectType=article, longId=216260, objectId=c3532162608a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3532162608a, replyNumber=0, likeNumber=40, createdTime=2022-07-16, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3532162608a, moduleTitle=科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3532162608a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748954, encodeId=d5461e4895491, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=EOC202海外试验显著改善晚期乳腺癌患者总生存期，亿腾景昂药业在中国启动该产品II期临床, objectType=article, longId=204591, objectId=0d4f2045916e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d4f2045916e, replyNumber=0, likeNumber=41, createdTime=2021-07-16, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d4f2045916e, moduleTitle=EOC202海外试验显著改善晚期乳腺癌患者总生存期，亿腾景昂药业在中国启动该产品II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d4f2045916e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748957, encodeId=20091e4895751, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=复星医药上半年净利增44.77% ，海外收入占比突破30%, objectType=article, longId=216241, objectId=7eaf2162418c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eaf2162418c, replyNumber=0, likeNumber=42, createdTime=2022-02-02, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eaf2162418c, moduleTitle=复星医药上半年净利增44.77% ，海外收入占比突破30%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eaf2162418c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748955, encodeId=f4c51e4895512, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权, objectType=article, longId=205683, objectId=7caf20568388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7caf20568388, replyNumber=0, likeNumber=38, createdTime=2021-03-31, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7caf20568388, moduleTitle=诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7caf20568388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748952, encodeId=403e1e489525a, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=Sight diagnostics：AI赋能血液分析，用微量指尖血检测19项参数【海外案例】, objectType=article, longId=199838, objectId=fe3a1998380b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3a1998380b, replyNumber=0, likeNumber=36, createdTime=2020-10-26, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3a1998380b, moduleTitle=Sight diagnostics：AI赋能血液分析，用微量指尖血检测19项参数【海外案例】, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3a1998380b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748949, encodeId=fbf01e48949f6, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外, objectType=article, longId=191589, objectId=4964191589d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4964191589d9, replyNumber=0, likeNumber=39, createdTime=2021-02-24, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4964191589d9, moduleTitle=中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4964191589d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748953, encodeId=aa831e489533c, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=陈薇团队新冠疫苗海外开展三期临床试验, objectType=article, longId=200414, objectId=ced6200414c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced6200414c8, replyNumber=0, likeNumber=52, createdTime=2021-06-17, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced6200414c8, moduleTitle=陈薇团队新冠疫苗海外开展三期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced6200414c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748948, encodeId=f5951e4894839, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=3月18日新冠肺炎简报，海外确诊人数超115000例，意大利，伊朗，西班牙皆过万, objectType=article, longId=190251, objectId=4e4f19025121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e4f19025121, replyNumber=0, likeNumber=49, createdTime=2021-02-21, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e4f19025121, moduleTitle=3月18日新冠肺炎简报，海外确诊人数超115000例，意大利，伊朗，西班牙皆过万, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e4f19025121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748943, encodeId=657d1e4894388, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=英文版《中国艾滋病流行与防治》海外在线出版，介绍中国经验, objectType=article, longId=181340, objectId=9f5e18134064, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5e18134064, replyNumber=0, likeNumber=35, createdTime=2020-01-30, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5e18134064, moduleTitle=英文版《中国艾滋病流行与防治》海外在线出版，介绍中国经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5e18134064)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748950, encodeId=47431e489507c, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=中国“黑”科技助力海外疫情防控！, objectType=article, longId=191832, objectId=fbdb191832bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbdb191832bc, replyNumber=0, likeNumber=32, createdTime=2021-01-15, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbdb191832bc, moduleTitle=中国“黑”科技助力海外疫情防控！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbdb191832bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748944, encodeId=2c821e48944f5, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=海外医疗旅游乱象频发，行业规范来了！, objectType=article, longId=182417, objectId=a34718241e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34718241e6d, replyNumber=0, likeNumber=47, createdTime=2020-04-16, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34718241e6d, moduleTitle=海外医疗旅游乱象频发，行业规范来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34718241e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748945, encodeId=575c1e489459d, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=海外21个国家出现新冠肺炎病例他们在如何应对？, objectType=article, longId=187332, objectId=bae718e33283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bae718e33283, replyNumber=0, likeNumber=42, createdTime=2020-03-08, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bae718e33283, moduleTitle=海外21个国家出现新冠肺炎病例他们在如何应对？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bae718e33283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748946, encodeId=6fa11e489468f, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=新冠肺炎疫情海外肆虐世卫组织说的"大流行”是什么意思？, objectType=article, longId=189931, objectId=88be18993164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88be18993164, replyNumber=0, likeNumber=42, createdTime=2020-11-08, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88be18993164, moduleTitle=新冠肺炎疫情海外肆虐世卫组织说的"大流行”是什么意思？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88be18993164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748951, encodeId=bf5b1e4895164, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高, objectType=article, longId=192922, objectId=1aaa1929229c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aaa1929229c, replyNumber=0, likeNumber=31, createdTime=2021-03-30, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aaa1929229c, moduleTitle=张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aaa1929229c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1748947, encodeId=09731e4894761, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, objectTitle=新冠肺炎：意大利超过17000例，海外已超过6万例, objectType=article, longId=189986, objectId=a212189986b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a212189986b8, replyNumber=0, likeNumber=29, createdTime=2020-05-11, rootId=0, userName=lishizhe, userId=82fd36209189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a212189986b8, moduleTitle=新冠肺炎：意大利超过17000例，海外已超过6万例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a212189986b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

海外

2020-05-29

lishizhe (审核中...)

前往app查看评论内容

#海外#

恒瑞医药率先进军海外创新药市场，正式推出Luzsana公司

2022-08-23

lishizhe (审核中...)

前往app查看评论内容

#海外#

2022年4月23日简报：上海昨日新增本土病例“2736+20634”例，死亡12例；香港将从5月1日起允许非香港居民从海外入境；美国纽约BA.2.12和BA.2.12.1在迅速传播

2022-09-16

lishizhe (审核中...)

前往app查看评论内容

#海外#

香港新增574例新冠肺炎确诊病例，5月起容许非香港居民从海外入境（2022.04.22）

2022-10-20

lishizhe (审核中...)

前往app查看评论内容

#海外#

【海外病例精选18期】黄色肉芽肿性肾盂肾炎

2022-04-10

lishizhe (审核中...)

前往app查看评论内容

#海外#

荣昌生物与西雅图基因签约：26亿美元！维迪西妥单抗创单药海外授权新纪录

2022-05-03

lishizhe (审核中...)

前往app查看评论内容

#海外#

科济药业发布2021年中期业绩自主研发 CAR-T候选品进入海外关键II期临床试验

2022-07-16

仁医06 (审核中...)

前往app查看评论内容

#海外#

EOC202海外试验显著改善晚期乳腺癌患者总生存期，亿腾景昂药业在中国启动该产品II期临床

2021-07-16

lishizhe (审核中...)

前往app查看评论内容

#海外#

复星医药上半年净利增44.77% ，海外收入占比突破30%

2022-02-02

lishizhe (审核中...)

前往app查看评论内容

#海外#

诺华支付6.5亿美元用于百济神州抗PD-1药物tislelizumab的海外使用权

2021-03-31

lishizhe (审核中...)

前往app查看评论内容

#海外#

Sight diagnostics：AI赋能血液分析，用微量指尖血检测19项参数【海外案例】

2020-10-26

lishizhe (审核中...)

前往app查看评论内容

#海外#

中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外

2021-02-24

lishizhe (审核中...)

前往app查看评论内容

#海外#

陈薇团队新冠疫苗海外开展三期临床试验

2021-06-17

lishizhe (审核中...)

前往app查看评论内容

#海外#

3月18日新冠肺炎简报，海外确诊人数超115000例，意大利，伊朗，西班牙皆过万

2021-02-21

lishizhe (审核中...)

前往app查看评论内容

#海外#

英文版《中国艾滋病流行与防治》海外在线出版，介绍中国经验

2020-01-30

lishizhe (审核中...)

前往app查看评论内容

#海外#

中国“黑”科技助力海外疫情防控！

2021-01-15

lishizhe (审核中...)

前往app查看评论内容

#海外#

海外医疗旅游乱象频发，行业规范来了！

2020-04-16

lishizhe (审核中...)

前往app查看评论内容

#海外#

海外21个国家出现新冠肺炎病例他们在如何应对？

2020-03-08

lishizhe (审核中...)

前往app查看评论内容

#海外#

新冠肺炎疫情海外肆虐世卫组织说的"大流行”是什么意思？

2020-11-08

lishizhe (审核中...)

前往app查看评论内容

#海外#

张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高

2021-03-30

lishizhe (审核中...)

前往app查看评论内容

#海外#

新冠肺炎：意大利超过17000例，海外已超过6万例

2020-05-11

科室
- - 订阅+
  - 更多科室
工具
服务